DE1931956A1 - Impfstoff gegen Vogelleukose - Google Patents
Impfstoff gegen VogelleukoseInfo
- Publication number
- DE1931956A1 DE1931956A1 DE19691931956 DE1931956A DE1931956A1 DE 1931956 A1 DE1931956 A1 DE 1931956A1 DE 19691931956 DE19691931956 DE 19691931956 DE 1931956 A DE1931956 A DE 1931956A DE 1931956 A1 DE1931956 A1 DE 1931956A1
- Authority
- DE
- Germany
- Prior art keywords
- virus
- lymphoid
- tissue
- erythroblastosis
- leukosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000271566 Aves Species 0.000 title claims description 47
- 229960005486 vaccine Drugs 0.000 title claims description 42
- 208000032839 leukemia Diseases 0.000 title description 7
- 241000700605 Viruses Species 0.000 claims description 46
- 210000004027 cell Anatomy 0.000 claims description 31
- 206010049466 Erythroblastosis Diseases 0.000 claims description 30
- 210000001519 tissue Anatomy 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 238000002255 vaccination Methods 0.000 claims description 16
- 244000144977 poultry Species 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 208000028018 Lymphocytic leukaemia Diseases 0.000 claims description 9
- 208000003747 lymphoid leukemia Diseases 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 230000036039 immunity Effects 0.000 claims description 6
- 230000003053 immunization Effects 0.000 claims description 6
- 210000000952 spleen Anatomy 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 210000004907 gland Anatomy 0.000 claims description 5
- 238000002649 immunization Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000007918 pathogenicity Effects 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000006194 liquid suspension Substances 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 239000011872 intimate mixture Substances 0.000 claims 4
- 239000007928 intraperitoneal injection Substances 0.000 claims 2
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 210000000265 leukocyte Anatomy 0.000 claims 1
- 210000005228 liver tissue Anatomy 0.000 claims 1
- 210000005084 renal tissue Anatomy 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 description 23
- 235000013330 chicken meat Nutrition 0.000 description 23
- 201000010099 disease Diseases 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 239000002054 inoculum Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 244000144980 herd Species 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000286209 Phasianidae Species 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 231100000676 disease causative agent Toxicity 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 244000144992 flock Species 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 230000004719 natural immunity Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 208000004729 Feline Leukemia Diseases 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000027954 Poultry disease Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 244000144987 brood Species 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000028756 lack of coordination Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000009374 poultry farming Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73962268A | 1968-06-25 | 1968-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1931956A1 true DE1931956A1 (de) | 1970-01-15 |
Family
ID=24973116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19691931956 Pending DE1931956A1 (de) | 1968-06-25 | 1969-06-24 | Impfstoff gegen Vogelleukose |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3590128A (enExample) |
| BR (1) | BR6910100D0 (enExample) |
| CH (1) | CH506622A (enExample) |
| DE (1) | DE1931956A1 (enExample) |
| FR (1) | FR2014188B1 (enExample) |
| GB (1) | GB1230890A (enExample) |
| NL (1) | NL6909516A (enExample) |
| ZA (1) | ZA693919B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3981771A (en) * | 1973-07-19 | 1976-09-21 | Martin Sevoian | Marek's disease vaccine |
-
1968
- 1968-06-25 US US739622A patent/US3590128A/en not_active Expired - Lifetime
-
1969
- 1969-06-02 GB GB1230890D patent/GB1230890A/en not_active Expired
- 1969-06-02 ZA ZA693919A patent/ZA693919B/xx unknown
- 1969-06-20 NL NL6909516A patent/NL6909516A/xx unknown
- 1969-06-24 DE DE19691931956 patent/DE1931956A1/de active Pending
- 1969-06-24 FR FR696921164A patent/FR2014188B1/fr not_active Expired
- 1969-06-24 BR BR210100/69A patent/BR6910100D0/pt unknown
- 1969-06-25 CH CH974069A patent/CH506622A/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA693919B (en) | 1971-01-27 |
| FR2014188A1 (enExample) | 1970-04-17 |
| US3590128A (en) | 1971-06-29 |
| NL6909516A (enExample) | 1969-12-30 |
| GB1230890A (enExample) | 1971-05-05 |
| BR6910100D0 (pt) | 1973-02-27 |
| FR2014188B1 (enExample) | 1973-01-12 |
| CH506622A (de) | 1971-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69422501T2 (de) | Kompetitiv verdrängende schleimhautflora | |
| DE69032207T2 (de) | Einführung von bakterien in ovo | |
| DE69925371T2 (de) | Impfstoff für geflügel | |
| DE69030383T2 (de) | Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten | |
| DE3882599T2 (de) | Hundecoronavirus-Impfstoff. | |
| Kaschula | A new virus disease of the muscovy-duck [Cairina moschata (linn)] present in Natal | |
| DE3886999T3 (de) | Newcastle-krankheitsvirus-Impfstoff und Methode für seine Verwendung. | |
| DE2409862C3 (de) | Verwendung einer oral applizierbaren Immunoglobulinkombination | |
| DE1957747A1 (de) | Impfstoffe und Verfahren zu ihrer Herstellung | |
| AT393453B (de) | Verfahren zum schutz eines tieres gegen coccidiose | |
| DE1198489B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie | |
| DE1931956A1 (de) | Impfstoff gegen Vogelleukose | |
| DE2620287A1 (de) | Verfahren zur wachstumsfoerderung von tieren | |
| DE3878982T2 (de) | Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus. | |
| DE833673C (de) | Verfahren zur Herstellung einer Schweinecholera-Lymphe | |
| DE60114908T2 (de) | Hühner-Anäemie-Virus mit geringer Pathogenität | |
| DE2045160A1 (de) | Verfahren zur Herstellung einer Lebendvaccine gegen die infektiöse Bursitis der Huhner | |
| Connor | Effects of adrenal cortical extracts upon the sex organs of animals | |
| DE191752C (enExample) | ||
| DE2126957A1 (de) | Impfstoff gegen Gänsehepatitis | |
| Reece et al. | Common necropsy findings in captive birds in Victoria, Australia (1978-1987) | |
| Bushnell | Bacillary white diarrhea in fowl | |
| Maas et al. | The development of two White Plymouth Rock lines resistant to Marek's disease by breeding from survivors | |
| DE2225548A1 (de) | Intravenoes vertraegliche staupe- und hepatitisvaccine | |
| Maas et al. | Age related resistance to avian Leukosis virus II. influence of age at inoculation on mortality and congenital transmission |